Skip to main content
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · IEX Real-Time Price · USD
4.520
0.00 (0.00%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Zevra Therapeutics Revenue

In the year 2023, Zevra Therapeutics had annual revenue of $27.46M with 170.26% growth. Revenue in the quarter ending December 31, 2023 was $13.22M with 553.66% year-over-year growth.

Revenue (ttm)
$27.46M
Revenue Growth
+170.26%
P/S Ratio
7.15
Revenue / Employee
$422,477
Employees
65
Market Cap
196.29M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202327.46M17.30M170.26%
Dec 31, 202210.16M-18.49M-64.53%
Dec 31, 202128.65M15.36M115.61%
Dec 31, 202013.29M449.00K3.50%
Dec 31, 201912.84M--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rigel Pharmaceuticals 116.88M
Lifecore Biomedical 103.27M
Innate Pharma 68.49M
Profound Medical 5.41M
Actinium Pharmaceuticals 81.00K
Revenue Rankings

ZVRA News

More News